A systematic review and meta-analysis evaluating the effectiveness and safety of the swallowable intragastric balloon was recently published. The analysis reviewed studies conducted between 2016 and 2024 and included data from 11 observational studies comprising a total of 2,107 patients.
Key Findings from the Study
- Weight Loss: The study found that using the swallowable balloon led to an average weight loss of about 12.5% of body weight.
- Safety: The research showed a low rate of serious side effects (only 0.9% of participants experienced significant issues), indicating that this method is generally safe for most people.
- Health Improvements: Participants also saw improvements in important health markers, such as cholesterol levels and blood sugar, which can help reduce the risk of other health problems related to obesity.
Why It Matters
Losing just 5% to 10% of body weight can lead to significant health benefits, such as lower risks of heart disease and diabetes. The swallowable balloon offers an effective, minimally invasive option for those struggling with obesity, making it easier to start the journey toward better health.
What to Consider
While the swallowable intragastric balloon shows promise, it’s important to note that it is delivered as part of a behaviour modification programme that lasts for a minimum of 6 months.
Conclusion
The swallowable intragastric balloon presents a new, effective way to help individuals lose weight. As with any weight loss method, combining it with healthy eating and regular physical activity is crucial for achieving lasting results.
REFERENCE:
Silva, A.F., Bestetti, A.M., Kum, A.S.T. et al. Effectiveness and Safety of the Allurion Swallowable Intragastric Balloon for Short-term Weight Loss: A Systematic Review and Meta-analysis. OBES SURG (2024). https://doi.org/10.1007/s11695-024-07453-5